Medical Linear Accelerator Market Size, Share, Industry, Forecast and outlook (2024-2031)

Medical Linear Accelerator Market is Segmented By Product Type (Dedicated Linear Accelerator, Non-Dedicated Linear Accelerator), By Treatment Type (Stereotactic Radiosurgery/Stereotactic Body Radiotherapy, Intensity Modulated Radiation Therapy, Volumetric Modulated Arc Therapy, Image-Guided Radiation Therapy), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030 

Medical Linear Accelerator Market Overview

The Medical Linear Accelerator Market report analyzes the global market size, shares, recent trends, competitive intelligence, and future market outlook. Medical linear accelerators are advanced medical devices used for external beam radiation therapy in the treatment of cancer. They deliver high-energy X-rays to target and destroy cancer cells while minimizing damage to surrounding healthy tissues. The market is driven by the increasing incidence of cancer, the growing demand for precise and effective cancer treatment, and technological advancements in radiation therapy. In Asia Pacific, the Medical Linear Accelerator Market is witnessing significant growth. Key players in the market include Varian Medical Systems, Elekta AB, Accuray Incorporated, and other prominent players.

A medical linear accelerator uses X-rays of high energy and takes the shape of a tumor to destroy it while leaving the healthy cells. It is commonly practiced in external radiotherapy.

Medical Linear Accelerator Market Insights

For more insights - Download the Sample

Medical Linear Accelerator Market Dynamics and Trends

Medical Linear Accelerator Market growth is driven by the rise in prevalence of cancer. Furthermore, the advantages of LINACs over other conventional devices and the increase in awareness & availability of LINACs in medical settings boost the market growth.

Consultation companies are innovating in electron radiation and x-ray radiation LINAC systems coupled with the rise in the prevalence of cancer is expected to drive the growth in the forecast period

According to Cancer Research UK, approximately 17 million people were diagnosed with cancer globally in 2018. Moreover, most cancers are diagnosed at the last stage of it. Hence, as cancer incidence increases, the demand for treatment will also increase and thereby be expected to boost the medical linear accelerator market growth. Moreover, high-energy linear particle accelerators are helping manufacturers gain a competitive edge in the healthcare landscape. For instance, Altair— a healthcare and clinical analytics solutions company, offers custom solutions to manufacturers in the linear accelerators (LINAC) market. Healthcare consultation companies are entering into contractual agreements with equipment manufacturers to innovate LINACs. This has led to the expansion of testing and tuning facilities. Consultation companies are establishing in-house testing facilities that validate the refurbishment cost of LINACs.

Consultation companies in the linear accelerators (LINAC) market acquire proficiency in repairing, designing, and supplying equipment. This benefits medical OEMs and other research entities. OEMs are increasing their production capacities to develop electron radiation and X-ray radiation LINACs. They are increasing the availability of turnkey LINACs that deploy various energy outputs.

The lack of skilled and experienced personnel is likely to hamper the market growth

Linear Accelerator Market however faces various challenges such as limited literature being available regarding the outcomes of the device usage, linear accelerator devices is not supported by evidence-based outcome studies, difficulty in visualizing tumors before targeting them, and the major concern is affordability and accessibility of the treatment. A shortage of trained personnel to prescribe appropriate dosage and sessions is observed in the linear accelerator market. The lack of skilled healthcare personnel is projected to restrain the global linear accelerators (LINAC) market. Key healthcare professionals involved in radiation therapy are radiation therapy specialists, oncologists, and radiation dosimetrists. In developing countries, a lack of skilled and trained healthcare professionals is a major pitfall in providing treatment to patients. These professionals must know about dosage, amount of radiation, and other factors to deliver successful treatment.

In 2018, there were nearly 2,000 oncologists for 10 million cancer patients in India. One of the major concerns is the concentration of oncologists in India. The majority of radiation facilities and oncologists are concentrated in the metropolitan cities of India, hampering equitable access to treatment.

COVID-19 Impact on Medical Linear Accelerator Market Growth

Though the coronavirus (COVID-19) pandemic continues to surge in the U.S., healthcare facilities are being consistent in providing their services to patients. As such, ease in lockdown restrictions in the U.S. has helped equipment personnel to efficiently install and remove linear accelerators in hospital systems. However, quarantining immigrants from hot zone states is likely to interfere with the smooth delivery of healthcare services. This might hamper the growth of the linear accelerators (LINAC) market. As such, medical workers are exempt from quarantine restrictions to ensure the efficient removal and installation of medical equipment.

Equipment engineers are recommended to wear personal protective equipment (PPE) while replacing and installing linear accelerators. Sterilization and sanitization of PPE are becoming crucial amidst the COVID-19 pandemic. As such, cancer patients continue to receive treatments from linear accelerators. These factors are expected to drive the linear accelerators (LINAC) market during the forecast period.

Medical Linear Accelerator Market Segment Analysis

The stereotactic radiosurgery/stereotactic body radiotherapy segment is expected to hold the largest share in this market segment

Stereotactic radiosurgery and stereotactic body radiotherapy is a type of external radiotherapy that uses high-energy photons to destroy cancerous cells while sparing healthy cells. Linear accelerator-based stereotactic radiosurgery is rapidly increasing for the treatment of cancer and other neurological disorder such as trigeminal neuralgia. One of the studies published in 2017, by the Journal of Applied Clinical Medical Physics revealed that linear accelerator-based stereotactic surgery was found to be very effective in the case of trigeminal neuralgia. Furthermore, with the wide acceptance of non-invasive surgery, the market is expected to increase.

Medical Linear Accelerator Market Geographical Share

North American region holds the largest market share of the global medical linear accelerator market

North America is expected to hold a major market share in the global medical linear accelerator market due to the growing burden of diseases such as cancer and trigeminal neuralgia. According to the Trigeminal Neuralgia Association of Canada, almost every year 5 per 100,000 people are diagnosed with trigeminal neuralgia in Canada. Furthermore, according to National Organization for Rare Disorders, trigeminal neuralgia is affecting between 10,000 to 15,000 people each year in the United States. One of its treatments includes stereotactic surgery by using a modified linear accelerator. Thus, these factors are expected to propel the medical linear accelerator market growth in North America.

Medical Linear Accelerator Market Companies and Competitive Landscape

The global medical linear accelerator market is moderately competitive with the presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Accuray Inc, Elekta AB, Viewray Technologies Inc, Shinva Medical Instrument Co. Ltd, Panacea Medical Technologies, Brainlab AG, Altair Technologies Inc., and Siemens Healthineers. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the Medical Linear Accelerator globally.  For instance, In June 2020, Teledyne e2v US, a business unit of Teledyne Digital Imaging US, Inc., appointed RS&A Inc, the United States-based independent service provider of medical equipment, as the distributor of its linear accelerator medical and industrial products in the Americas.

Medical Linear Accelerator Market – Key Companies to Watch